Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-001842

CEO and CFO bought 2,500 shares at $12.51 ($31,275)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-01-10 Purchase +2,500 $12.51 $31,275 5,552,502 D
Open-market purchases · 2,500 sh · avg $12.51 · $31,275
Loading xslF345X05/ownership.xml…